Vijan S - Search Results

1

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.

Vijan S, Hayward RA. Vijan S, et al. Ann Intern Med. 2003 Apr 1;138(7):593-602. doi: 10.7326/0003-4819-138-7-200304010-00018. Ann Intern Med. 2003. PMID: 12667032 Review.

2

Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Vijan S, et al. J Gen Intern Med. 1997 Sep;12(9):567-80. doi: 10.1046/j.1525-1497.1997.07111.x. J Gen Intern Med. 1997. PMID: 9294791 Free PMC article. Review.

3

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

Vijan S, Hofer TP, Hayward RA. Vijan S, et al. Ann Intern Med. 1997 Nov 1;127(9):788-95. doi: 10.7326/0003-4819-127-9-199711010-00003. Ann Intern Med. 1997. PMID: 9382399

4

Normative issues in cost effectiveness analysis.

Goold SD, Vijan S. Goold SD, et al. Among authors: vijan s. J Lab Clin Med. 1998 Nov;132(5):376-82. doi: 10.1016/s0022-2143(98)90108-1. J Lab Clin Med. 1998. PMID: 9823931 Review.

5

Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus?

Vijan S, Kent DM, Hayward RA. Vijan S, et al. Diabetologia. 2000 Jan;43(1):125-30. doi: 10.1007/s001250050017. Diabetologia. 2000. PMID: 10672454 Review.

6

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

Vijan S, Hofer TP, Hayward RA. Vijan S, et al. JAMA. 2000 Feb 16;283(7):889-96. doi: 10.1001/jama.283.7.889. JAMA. 2000. PMID: 10685713

7

How often should patients with diabetes Be screened for retinopathy?

Vijan S, Hofer TP, Hayward RA. Vijan S, et al. JAMA. 2000 Jul 26;284(4):437-9. JAMA. 2000. PMID: 10904498 No abstract available.

8

Estimating the microvascular benefits of screening for type 2 diabetes mellitus.

Hofer TP, Vijan S, Hayward RA. Hofer TP, et al. Among authors: vijan s. Int J Technol Assess Health Care. 2000 Summer;16(3):822-33. doi: 10.1017/s0266462300102090. Int J Technol Assess Health Care. 2000. PMID: 11028137

9

The cost-utility of screening for depression in primary care.

Valenstein M, Vijan S, Zeber JE, Boehm K, Buttar A. Valenstein M, et al. Among authors: vijan s. Ann Intern Med. 2001 Mar 6;134(5):345-60. doi: 10.7326/0003-4819-134-5-200103060-00007. Ann Intern Med. 2001. PMID: 11242495

10

Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures.

Kerr EA, Krein SL, Vijan S, Hofer TP, Hayward RA. Kerr EA, et al. Among authors: vijan s. Am J Manag Care. 2001 Nov;7(11):1033-43. Am J Manag Care. 2001. PMID: 11725807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results